99mTc-MIRC213

N/A

Report date: 2025/09/22 17:35:18

Base Information

Drug Name99mTc-MIRC213
Drug Alias Name99-mTc-MIRC-213
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionSingle-photon emission-computed tomography enhancers
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPeking Union Medical College Hospital
China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College Hospital
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A